Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4
- 31 December 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (7), 867-872
- https://doi.org/10.1016/s0960-894x(01)80253-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residuesJournal of Medicinal Chemistry, 1992
- Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonistsJournal of Medicinal Chemistry, 1991
- Development of CCK-B antagonistsNeuropeptides, 1991
- Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesJournal of Medicinal Chemistry, 1991
- Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonistsJournal of Medicinal Chemistry, 1990
- On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.Proceedings of the National Academy of Sciences, 1987
- Synthesis and binding affinities of analogs of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptorsJournal of Medicinal Chemistry, 1987
- Phenylethylamide derivatives of the C‐terminal tetrapeptide of gastrinInternational Journal of Peptide and Protein Research, 1986
- Synthesis and biological activities of some pseudo-peptide analogs of tetragastrin: the importance of the peptide backboneJournal of Medicinal Chemistry, 1985
- Conformational properties of gastrin fragments of increasing chain lengthBiopolymers, 1985